MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
about
Role of microRNAs in chemoresistanceMicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy EfficacyUsefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02.Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.MiRNAs-mediated cisplatin resistance in breast cancer.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.MicroRNA-326 Sensitizes Human Glioblastoma Cells to Curcumin via the SHH/GLI1 Signaling Pathway.miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation.MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
P2860
Q26770485-50E74BE8-1257-4688-963E-13977A9046ADQ28829013-4332E844-6ED5-4784-AA29-64631854DA79Q33599465-DE542F2C-4A5D-46D3-A1B1-A18D50C9FF97Q33838622-BA39DFA4-DC05-487F-8CBB-C9B106FC4D34Q33879017-37474881-B2D8-4DFC-866F-A529A9D12EACQ36908874-E22ED606-D0AE-4C20-B16A-CC42EAC42B6FQ37190254-EF2EA4A9-0BBB-447F-B379-6D7FE09C6100Q38429163-FF64EA05-086C-4290-8CBC-282B547C6AC1Q38905681-BD37BDAB-3F64-4366-9738-4BAE7148DBECQ38958559-259B17DE-BC3F-4A76-97A4-E59724E371AEQ39209850-0DC7DC26-D404-4A25-867C-40FD90ECE888Q41082524-5F777866-85DE-436C-B8C0-1838C19E359CQ42368096-16558939-2B2A-4F83-962B-9F87E2D8A4ADQ57106460-853A35A6-8A82-4FA5-BBBB-52B0C351C323
P2860
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
@en
type
label
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
@en
prefLabel
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
@en
P2093
P2860
P1433
P1476
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
@en
P2093
Hongwu Deng
Nengbin Wan
Xiefu Zhang
Zhengyu Zhou
P2860
P2888
P304
P356
10.1007/S13277-014-2814-Z
P577
2014-11-15T00:00:00Z
P6179
1002830407